4/15
01:18 pm
ntbl
Notable Labs, Ltd. (NASDAQ: NTBL) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $9.00 price target on the stock.
Low
Report
Notable Labs, Ltd. (NASDAQ: NTBL) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $9.00 price target on the stock.
4/15
08:11 am
ntbl
Notable Labs, Ltd. (NASDAQ: NTBL) had its price target lowered by analysts at Chardan Capital from $9.00 to $7.00. They now have a "buy" rating on the stock.
Low
Report
Notable Labs, Ltd. (NASDAQ: NTBL) had its price target lowered by analysts at Chardan Capital from $9.00 to $7.00. They now have a "buy" rating on the stock.
4/12
08:00 am
ntbl
Notable Labs Reports 2023 Financial Results and Provides a Business Update
Low
Report
Notable Labs Reports 2023 Financial Results and Provides a Business Update
4/9
05:15 pm
ntbl
Notable Labs Presents the Design Plan for the PPMP-Enabled Phase 2 Trial with Volasertib for Relapsed/Refractory AML at AACR 2024
High
Report
Notable Labs Presents the Design Plan for the PPMP-Enabled Phase 2 Trial with Volasertib for Relapsed/Refractory AML at AACR 2024
4/8
12:00 pm
ntbl
Notable Labs Presentation of Data Related to Innovations in the Use of Cryopreserved Samples in the PPMP Assay at AACR 2024 Expands the Potential of the Platform
Medium
Report
Notable Labs Presentation of Data Related to Innovations in the Use of Cryopreserved Samples in the PPMP Assay at AACR 2024 Expands the Potential of the Platform
3/5
04:35 pm
ntbl
Notable Labs to Present Two Posters at AACR 2024 on PPMP Platform
Medium
Report
Notable Labs to Present Two Posters at AACR 2024 on PPMP Platform
3/5
04:42 am
ntbl
Notable Labs to Present Two Posters at AACR 2024 on PPMP Platform [Yahoo! Finance]
Low
Report
Notable Labs to Present Two Posters at AACR 2024 on PPMP Platform [Yahoo! Finance]
3/5
04:35 am
ntbl
Notable Labs to Present Two Posters at AACR 2024 on PPMP Platform
Low
Report
Notable Labs to Present Two Posters at AACR 2024 on PPMP Platform
2/22
08:09 am
ntbl
Notable Advances Volasertib Phase 2 Program Utilizing Proprietary Predictive Precision Medicine Platform-Guided Enrollment [Yahoo! Finance]
Medium
Report
Notable Advances Volasertib Phase 2 Program Utilizing Proprietary Predictive Precision Medicine Platform-Guided Enrollment [Yahoo! Finance]
2/22
08:00 am
ntbl
Notable Advances Volasertib Phase 2 Program Utilizing Proprietary Predictive Precision Medicine Platform-Guided Enrollment
Neutral
Report
Notable Advances Volasertib Phase 2 Program Utilizing Proprietary Predictive Precision Medicine Platform-Guided Enrollment